Community post

Mian Li Ooi and colleagues at the University of Adelaide and Ampliphi Biosciences published a paper on their use of phage therapy in a phase I clinical trial to treat patients with chronic rhinosinusitis caused by Staphylococcus aureus. They found that intranasal irrigation with phage cocktail AB-SA01 was safe and well tolerated, and they saw promising preliminary efficacy results.